Exhibit 107
Calculation of Filing Fee Table
(Form Type)
Travere Therapeutics, Inc.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered Securities
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
| |
|
|
|
|
|
|
|
|
| |
|
Security Type |
|
Security Class Title |
|
Fee
Calculation
or Carry
Forward
Rule |
|
Amount Registered |
|
Proposed
Maximum
Offering
Price Per
Share |
|
Maximum
Aggregate
Offering Price |
|
Fee Rate |
|
Amount of
Registration
Fee(1) |
| |
|
|
|
|
|
|
|
|
| Fees to be Paid |
|
Equity |
|
Common stock, par value $0.0001 per share |
|
Rule 457(r) |
|
8,984,375 (2) |
|
$16.00 |
|
$143,750,000 |
|
$153.10 per $1,000,000 |
|
$22,008.13 |
| |
|
|
|
|
|
| |
|
Total Offering Amounts |
|
— |
|
$143,750,000 |
|
— |
|
$22,008.13 |
| |
|
|
|
|
|
| |
|
Total Fees Previously Paid |
|
| |
| |
| |
— |
| |
|
|
|
|
|
| |
|
Total Fee Offsets |
|
| |
| |
— |
|
— |
| |
|
|
|
|
|
| |
|
Net Fee Due |
|
|
|
|
|
— |
|
$22,008.13 |
(1) Calculated in accordance with Rule 457(r) under the Securities Act of 1933, as amended (the “Securities Act”). Payment of the registration fee at the time of filing of the registrant’s Registration Statement on Form
S-3
(File
No. 333-281194)
on August 1, 2024 was deferred pursuant to Rules 456(b) and 457(r) under the Securities Act and is paid herewith.
(2) Includes 1,171,875 shares of common stock that the underwriters have an option to purchase.